-Float = 27M
-Nov 10 2020: Announces Bemarituzumab Plus Chemotherapy Demonstrates Significant Progression-Free and Overall Survival Benefit Compared to Placebo
-Nov 11 2020: Multiple PT upgrades
-SPY pattern: Consolidation
-Intraday pattern: Bear Flag
-Other notes: N/a
Strategy: First Test long of 24 level in PM
Confluence: Whole $, VWAP
Strike Zone: 24.5 - 23.5
Sizing (lots + emergency): 200
Risk (stop / Rs): Hold below 23.5
This was an A+ setup to take but it simply didn't bounce. Mentor's thoughts on it was float was big so more bagged longs on macro view. Still don't regret taking trade as it was A+. -1R here
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-11-11 07:35:02 | FPRX | buy | $24.380 | long |
2020-11-11 07:35:17 | FPRX | buy | $24.350 | long |
2020-11-11 07:35:55 | FPRX | buy | $24.190 | long |
2020-11-11 07:36:47 | FPRX | buy | $24.200 | long |
2020-11-11 07:40:05 | FPRX | sell | $24.440 | long |
2020-11-11 07:41:05 | FPRX | buy | $23.740 | long |
2020-11-11 07:43:49 | FPRX | buy | $23.620 | long |
2020-11-11 07:43:56 | FPRX | sell | $23.500 | long |
2020-11-11 07:43:56 | FPRX | sell | $23.500 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!